Log In | Register
The agency approved a polypill to treat hypertension, and separate FDA advisory committees endorsed an investigational antiplatelet, grappled with safety issues involving a new spine device, and debated when it's okay to change endpoints in clinical trials
Washington Week: Nonstop Action As FDA Closes Out July
Seeded on Sun Aug 1, 2010 1:29 AM EDT
Article Source: medpagetoday.com- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (1)
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.
